Phase III Study of the Efficacy and Safety of Subcutaneous Versus Intravenous Tocilizumab Monotherapy in Patients With Rheumatoid Arthritis

OBJECTIVE: To evaluate the efficacious noninferiority of subcutaneous tocilizumab injection (TCZ-SC) monotherapy to intravenous TCZ infusion (TCZ-IV) monotherapy in Japanese patients with rheumatoid arthritis (RA) with an inadequate response to synthetic and/or biologic disease-modifying antirheumat...

Descripción completa

Detalles Bibliográficos
Autores principales: Ogata, Atsushi, Tanimura, Kazuhide, Sugimoto, Toyohiko, Inoue, Hiroshi, Urata, Yukitomo, Matsubara, Tsukasa, Kondo, Masakazu, Ueki, Yukitaka, Iwahashi, Mitsuhiro, Tohma, Shigeto, Ohta, Shuji, Saeki, Yukihiko, Tanaka, Toshio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2014
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225471/
https://www.ncbi.nlm.nih.gov/pubmed/23983039
http://dx.doi.org/10.1002/acr.22110

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225471/
https://www.ncbi.nlm.nih.gov/pubmed/23983039
http://dx.doi.org/10.1002/acr.22110

Ejemplares similares